Opening Arguments - OA420: DoJ Defending Trump in Carroll Case?

You've likely seen the headlines saying the DoJ wants to take over defending Trump against E. Jean Carroll, but you haven't heard it properly explained by our esteemed P. Andrew Torrez! So what's happening and is it normal? The answer might actually surprise you...

We also talk a little about Bob Woodward's recordings of Trump and how totally awesome it is that he kept them secret for 7 months to sell his book.

Links: Another Trump Judge Rate Not Qualified; Carroll v Trump; SDNY Docket; DoJ Statement for Intervention; 28 USC 2679; 28 U.S. Code § 1446 - Procedure for removal of civil actions.

The Gist - The QAnon Questions

On the Gist, Trump’s Nobel nomination.

In the interview, author and former FBI counter-terrorism staffer Clint Watts is here to talk about QAnon. He and Mike discuss the rise of the conspiracy theory and movement, why its belief structure is so murky, and the oddities of its marketing and merchandising arm. Watts will be back tomorrow for the second half of this conversation. His is the author of Messing With the Enemy: Surviving in a Social Media World of Hackers, Terrorists, Russians, and Fake News.

In the spiel, Woodward’s words wouldn’t have mattered.

Email us at thegist@slate.com

Podcast production by Daniel Schroeder, Margaret Kelley, and Lori Galarreta.

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Consider This from NPR - Why Are So Many Americans Hesitant To Get A COVID-19 Vaccine?

As trials continue for a coronavirus vaccine, some of the world's biggest drug companies have come together in an unusual way. This week, nine drugmakers released a joint statement pledging to not submit a coronavirus vaccine to the Food and Drug Administration unless it's shown to be safe and effective in large clinical trials.

NPR's Sydney Lupkin reports that the statement comes as a commitment to science, at a time when some Americans have expressed concern that the trials are being rushed.

Part of this concern comes from those who feel politics are influencing the processes vaccines must go through. The Centers for Disease Control and Prevention have told states a potential vaccine may be ready for distribution as soon as late October — right before Election Day. But when speaking with NPR's Mary Louise Kelly, Dr. Moncef Slaoui, chief scientific adviser to Operation Warp Speed, said there is a "very low chance" a vaccine will be ready by then.

While some Americans are skeptical about a coronavirus vaccine, it doesn't seem like many of those people work on Wall Street. Each time a new vaccine trial phase is announced or a new scientific hurdle is cleared, drug company stock goes up. NPR's Tom Dreisbach reported that executives at one company took advantage of those rising stock prices.

Find and support your local public radio station.

Email us at considerthis@npr.org

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Science In Action - Covid -19 science versus politics

With the announcement in the UK of investment in rapid testing for people who may not have Covid -19 we ask why is this only happening now? For months on this programme we’ve featured scientific research suggesting such a strategy would be the quickest way to end the pandemic.

We speak with Connie Cepko and Brian Rabe who have developed a rapid test and Manu Prakash who is currently rolling it out to countries in the global south.

Could a huge motorcycle rally really have been the source of over a quarter of a million Covid -19 infections? That’s the finding of a study by economist Andrew Friedson he tells us how mobile phone data helped to determine that figure.

And the politics of vaccines, Many health officials in the US have spoken out against president Trumps claim that a vaccine may be ready before the November presidential election. Helen Branswell from Stat news tells us why there is so much concern over political attempts to manipulate science.

(Image:Getty Images)

Presenter: Roland Pease Producer: Julian Siddle

The Government Huddle with Brian Chidester - The One with the GovBizResults CEO

Juliana Slye, CEO and Managing Principal of Government Business Results joins the show to discuss what marketers should be focused on as they build a strategy post-pandemic. We also deliberate ways marketers can duplicate the value of in-person events in today’s conditions and what programs her team has deployed on behalf of her clients that drove positive change.

Reset with Sasha-Ann Simons - Dozens Of Applicant Groups Question State’s Cannabis Equity Policies

Nearly two dozen groups are suing Illinois to keep new cannabis retail licenses from going to “politically connected” companies. Only 21 out of 700 groups qualified for the state’s lottery system to determine who will be allowed to open pot shops.

We’ll take a closer look at the state’s cannabis lottery system and why lawmakers say Black and brown business owners are being left behind.

CoinDesk Podcast Network - BREAKDOWN: How Monetary Policy Undermined American Resilience

A legacy of artificially low interest rates is not just the death of savings, but a forced buying into the perpetual growth machine of financial asset prices.

This episode is sponsored by Crypto.comBitstamp and Nexo.io.

Today on the Brief:

  • Jobless claims slightly exceed expectations at 884,000
  • ECB keeps policy unchained; euro rises versus dollar 
  • Survey: What’s the right way to understand the business and market cycle in the U.S. today? 


Our main discussion: interest rates and the undermining of American resilience. 

In this discussion, NLW looks at a number of artifacts of the low interest rate world, including:

  • Increasing cost of child care 
  • Declining share of total net worth held by bottom 50% 
  • New startups using lottery tactics to incentivize savers 


See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Everything Everywhere Daily - Who Discovered Calculus?

For the last 300 years, a debate has raged between mathematicians about who should be credited with the invention of calculus: Sir Isaac Newton or Gottfried Wilhelm Leibnitz. The sides of the debate have mostly been based on geography with English mathematicians advocating for Newton, and Continental Europeans siding with Leibnitz. Learn more about the war over calculus, even if you’ve never taken a calculus course in your life, on this episode of Everything Everywhere Daily.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Commentary Magazine Podcast - Hurricane Woodward

President Donald Trump stares into the storm as revelations he himself gave to Bob Woodward about how he deliberately downplayed the threat posed by COVID-19 dominate the news. He is, as ever, his own worst enemy. Also, the absurd and highly politicized reports around how gatherings of Trump supporters (and seemingly only Trump supporters) represent a public health emergency.

Learn more about your ad choices. Visit megaphone.fm/adchoices